Ainos, Inc. (AIMD) - Dilution Analysis

10-K filing | 7.3M shares outstanding

8-K filing: On December 30, 2025, Ainos, Inc. issued 1,160,000 shares of common stock to its wholly owned subsidiary, ScentAI Inc., in exchange for 116,000,000 shares of common stock to be issued by ScentAI.

10-Q filing | 4.6M shares outstanding

8-K filing: Stock split 1-for-5 | Outstanding: 20,764,225 → 4,152,845

10-Q filing | 20.8M shares outstanding

10-K filing | 15.4M shares outstanding

S-3/A filing: Registration for resale of up to 6,737,731 shares of common stock by selling shareholders.

S-3 filing: This prospectus relates to the resale of up to 6,737,731 shares of common stock by selling stockholders.

10-Q filing | 13.8M shares outstanding

8-K filing: Ainos, Inc. issued 5,500,000 shares of common stock to Taiwan Carbon Nano Technology Corporation (TCNT) for a patent license and 382,384 shares to Lind Global Fund II LP as part of a note conversion. ($0.22M proceeds)

10-Q filing | 7.7M shares outstanding

S-3 filing: The company may offer and sell up to $200 million in the aggregate of common stock, preferred stock and/or debt securities from time to time in one or more offerings.

10-Q filing | 5.8M shares outstanding

8-K filing: Ainos, Inc. entered into a Convertible Note and Warrant Purchase Agreement with ASE Test, Inc., issuing a convertible note for US$9,000,000 and a warrant to purchase up to 500,000 shares of common stock.

S-1 filing: An S-1 filing indicating that selling stockholders will determine the price at which they may sell securities.

10-K filing | 4.7M shares outstanding

8-K filing: Ainos, Inc. executed an agreement with Lind Global Fund II LP to raise additional financing in the principal amount of $1,750,000, with $875,000 funded at closing and the remainder subject to conditions. Warrants were issued to Lind and placement agents.

S-1/A filing: This S-1/A filing relates to the resale of up to 2,040,000 shares of common stock by selling stockholders, including shares issuable upon conversion of a promissory note and exercise of warrants.

8-K filing: Stock split 1-for-5 | Outstanding: 20,292,624 → 4,058,524

S-1 filing: This prospectus relates to the resale of up to 10,200,000 shares of common stock by selling stockholders, including shares issuable upon conversion of a promissory note and exercise of warrants.

8-K filing: Ainos, Inc. will issue 3,000,000 shares of common stock as Special Stock Awards to certain officers, directors, and management of the Company on or about November 24, 2023.

10-Q filing | 20.3M shares outstanding

8-K filing: AINOS, INC. entered into a securities purchase agreement with Lind Global Fund II LP for loans up to $10 million, issuing a convertible note for $3,540,000 and warrants to purchase 3,456,221 shares, and issued warrants to Maxim Partners LLC to purchase 53,333 shares at $1.65 per share as a placement agent fee.

10-Q filing | 20.1M shares outstanding

10-Q filing | 20.0M shares outstanding

10-K filing | 9.6M shares outstanding

10-Q filing | 19.5M shares outstanding

10-Q filing | 144.4M shares outstanding

8-K filing: Ainos, Inc. completed an offering of 780,000 units at $4.25 per unit, each unit consisting of one share of common stock and one warrant, and also completed a 1-for-15 reverse stock split. ($3.32M proceeds)

S-1/A filing: This S-1/A filing relates to Ainos, Inc.'s business plan which includes raising capital for research and development of POCT testing and medical treatment technologies. It discusses related party transactions, convertible notes payable, and the issuance of common stock in exchange for patent assignments.

S-1/A filing: This S-1/A filing registers 462,963 Units each consisting of one share of common stock and one warrant to purchase one share of common stock, with Maxim Group LLC as the sole book running manager. The company intends to list its common stock and warrants on the Nasdaq Capital Market under the symbols 'AIMD' and 'AIMDW', respectively.

S-1/A filing: This S-1/A filing describes an offering of units, each consisting of one share of common stock and one warrant to purchase one share of common stock, along with Representative's Warrants.

S-1/A filing: This is an S-1/A filing for a unit offering, each unit consisting of one share of common stock and one warrant to purchase one share of common stock. It also relates to the offering of common stock issuable upon exercise of the Warrants and Representative's Warrants.

10-Q filing | 144.4M shares outstanding

10-K filing | 144.4M shares outstanding

10-Q filing | 142.4M shares outstanding

10-Q filing | 142.3M shares outstanding

10-Q filing | 42.1M shares outstanding

10-K filing | 42.1M shares outstanding

10-Q filing | 41.0M shares outstanding

10-Q filing | 40.9M shares outstanding

10-Q filing | 40.5M shares outstanding

10-K filing | 40.5M shares outstanding